| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $901K | — | — |
| SG&A Expense | $11.3M | — | +2997.0% |
| Operating Income | -$12.2M | — | -3244.3% |
| Interest Expense | $8K | — | -99.0% |
| Net Income | -$35.1M | — | -8612.8% |
| EPS (Basic) | -$2.26 | — | -4420.0% |
| EPS (Diluted) | -$2.26 | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $980K | -40.2% | +291.3% |
| Short-term Investments | $1.5M | -25.0% | — |
| Current Assets | $13.2M | -5.9% | +4960.8% |
| Total Assets | $141.2M | -14.0% | — |
| Current Liabilities | $14.6M | +36.2% | +723.8% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | — |
| Capital Expenditures | $9K | — | — |
| Investing Cash Flow | $491K | — | — |
| Financing Cash Flow | $920K | — | +244.3% |
| Free Cash Flow | -$2.1M | — | — |
| -4420.0% |
| $14.7M |
| +35.7% |
| +627.8% |
| Stockholders' Equity | $126.5M | -17.5% | +7286.3% |